Isturisa denied as not medically necessary by Cigna?
Most insurers reverse a medical-necessity denial when the appeal cites the specific clinical guideline (NCCN, ADA, AACE, etc.) that supports the requested treatment for your indication.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Cigna typically requires
Cigna's specific coverage criteria for isturisa are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Cigna angle on Isturisa
## Why Cigna Denied Isturisa for Medical Necessity
A medical-necessity denial means Cigna's reviewer determined that the information submitted — or available in the record at the time of the decision — did not satisfy every criterion in the plan's coverage policy for Isturisa (osilodrostat). For a specialty drug used in Cushing's disease, these criteria typically address the confirmed diagnosis, the severity of active hypercortisolism, and the clinical history preceding the prescription.
Medical-necessity denials are frequently overturned on appeal when the clinical record is organized to directly address each policy criterion. A denial at the initial authorization stage does not mean the drug is excluded — it means the documentation gap needs to be closed.
## Federal Appeal Framework
- ACA §2719 / ERISA §503: You are entitled to a full-and-fair internal appeal. Cigna must provide you with the specific reason for denial and the clinical criteria applied upon request.
- Access to criteria: You have the right to receive a copy of the medical policy and any clinical guidelines used in the determination. Request these in writing immediately.
- External review: If the internal appeal is denied, escalate to an independent review organization (IRO). You generally have approximately four months from the denial date to file; confirm your exact deadline from the denial letter.
- Expedited review: If your condition makes delay medically dangerous, request expedited review at both the internal and external levels.
## Concrete Appeal Process and Timeline
1. Request the full denial reason and the Cigna medical policy used — you are entitled to these in writing. 2. Have the treating endocrinologist review the specific criteria and identify any documentation gaps in the current record. 3. Submit a written internal appeal with the complete clinical package (see below) within Cigna's stated deadline, typically 180 days from the denial. 4. Cigna must respond within 30 days (prospective/concurrent) or 60 days (retrospective). 5. If the internal appeal is denied, file for IRO external review before your four-month window closes.
## Documentation to Gather
- Diagnosis confirmation: Formal endocrinology evaluation confirming Cushing's disease — biochemical testing results (the type and interpretation, not raw numbers), pituitary imaging, and the clinical visit notes establishing the diagnosis.
- Prior-treatment history with dates and outcomes: A chronological list of every prior medical, surgical, or radiation treatment attempted — what was tried, when, for how long, and what the clinical outcome was. Chart notes are stronger than summary letters.
- Clinical severity per the chart: Current symptom burden and functional status as documented in office notes — not just a letter written for the appeal.
- Prescriber medical-necessity letter: A structured letter from the endocrinologist that maps each of Cigna's policy criteria to a specific fact in the medical record, explains why Isturisa is the appropriate next step, and references the FDA-approved prescribing information and the applicable endocrinology society guidelines.
## Criteria-Mapping Structure
Obtain Cigna's current coverage policy for Isturisa. For every listed criterion, create a two-column table:
| Cigna Policy Criterion | Chart Evidence (source, date) | |---|---| | Confirmed diagnosis of Cushing's disease | [Diagnostic workup, date, clinician] | | Inadequate response to or intolerance of prior therapy | [Prior agent, dates, documented outcome] | | Prescriber specialty requirement met | [Endocrinologist name, credentials] | | Other plan-specific criteria | [Corresponding chart documentation] |
Attach every referenced record. Reviewers — and IRO physicians — approve appeals fastest when the submission answers each criterion in order rather than presenting a general clinical narrative.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →